Glycemic Control Using Intrinsic Factor Bound to A Vitamin B12 Conjugate of a Glucagon-Like Peptide-1 Receptor Agonist
AssigneeSyracuse University
InventorsRobert Doyle, Jonathan D. Bortz, David S. Hermelin
Life of this patent
Estimating the term…
Abstract
The present invention provides compositions and methods for lowering blood glucose. More specifically, the present invention provides compositions comprising a complex comprising IF and B12 conjugated to a peptide comprising a GLP-1 agonist. Advantageously, the composition may be delivered subcutaneously.
Claims20
A method of enhancing a subcutaneously delivered target peptide, comprising the steps of:
- a) conjugating a molecule of B12 to the target peptide;
- and
- b) binding intrinsic factor to the conjugate of the molecule of B12 and the target peptide.
A method to lower blood glucose in a subject, the method comprising subcutaneously or intraperitoneally administering to the subject an effective amount of a pharmaceutical composition comprising intrinsic factor complexed with B12 or an analog thereof, wherein the B12 or analog thereof is conjugated to a peptide comprising a glucagon-like peptide-1 (GLP-1) receptor agonist.
A method of mitigating the effect of TCII sequestration of a B12 conjugate after administration of the conjugate to a subject, the method comprising complexing the B12 conjugate with IF before administering the complex to the subject.
Dependencies are inferred from the claim text.